Supriya Lifescience Results Earnings Call for Q4FY24

Conference Call with Supriya Lifescience Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.
29-05-2024
Bigul

Supriya Lifescience Ltd - 543434 - Corporate Action-Board approves Dividend

Considered and approved a dividend of Rs. 0.80 per equity shares of Rs. 2/- each
28-05-2024
Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Tuesday, May 28, 2024, inter-alia, has Considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2024 and Recommended the Final Dividend of Rs. 0.80 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting and others as per outcome of Board Meeting.
28-05-2024
Bigul

Supriya Lifescience Ltd - 543434 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find the Annual Secretarial Compliance Report.
27-05-2024
Next Page
Close

Let's Open Free Demat Account